A randomised controlled trial to study the side effect profile and to establish measures of efficacy using photofrin or 5-aminolaevulinic acid (ALA) photodynamic therapy in the eradication of dysplasia in Barrett's columnar lined oesophagus.

Trial Profile

A randomised controlled trial to study the side effect profile and to establish measures of efficacy using photofrin or 5-aminolaevulinic acid (ALA) photodynamic therapy in the eradication of dysplasia in Barrett's columnar lined oesophagus.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2013

At a glance

  • Drugs Aminolevulinic acid (Primary) ; Porfimer sodium (Primary)
  • Indications Barrett's oesophagus; High-grade oesophageal dysplasia; Oesophageal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 10 May 2011 Results presented at Digestive Disease Week 2011.
    • 25 Nov 2009 Interim results presented at Gastro 2009.
    • 05 Feb 2009 Status changed from not stated to completed, according to ISRCTN record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top